Product Information
NEBIVOLOL 20 MG TABLET is a generic product labeled by Modavar Pharmaceuticals LLC, priced at $0.1749 per EA under NDC 72241003504. Its NADAC has been published 174 times since Jun 1, 2022.
FDA first approved this application on Dec 17, 2021. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
20 mg/1
Manufacturer
Modavar Pharmaceuticals LLCNDC
72241003504
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NEBIVOLOL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208717FDA Approved
12/17/2021
TE Code
AB
On Market Since
12/29/2017
Pharmacological Classes
Price Statistics
The NADAC for NEBIVOLOL 20 MG TABLET has been published 174 times since Jun 1, 2022, and over the history we have for it it has declined 57.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1749 per EA |
|---|---|
| All-time high | $0.4284 (Jul 13, 2022) |
| All-time low | $0.1369 (Nov 20, 2024) |
| 52-week high | $0.1875 |
| 52-week low | $0.1749 |
| Median price | $0.1934 |
| Average price | $0.2322 |
| Largest weekly change | -42.9% (Nov 20, 2024) |
| Weeks tracked | 174 |
| Tracking since | Jun 1, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Modavar Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Nebivolol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NEBIVOLOL 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NEBIVOLOL 20 MG TABLET, manufactured by Modavar Pharmaceuticals LLC, is $0.1749 per EA (NDC 72241003504), effective Sep 30, 2026.
How has the price of NEBIVOLOL 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for NEBIVOLOL 20 MG TABLET has declined 57.0%. It has been tracked across 174 weekly CMS publications since Jun 1, 2022.
What are the highest and lowest recorded NADAC prices for NEBIVOLOL 20 MG TABLET?
Since Jun 1, 2022, the NADAC for NEBIVOLOL 20 MG TABLET has ranged from a low of $0.1369 (Nov 20, 2024) to a high of $0.4284 (Jul 13, 2022), with a median of $0.1934 per EA.
Are there cheaper alternatives to NEBIVOLOL 20 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as NEBIVOLOL 20 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures NEBIVOLOL 20 MG TABLET?
NEBIVOLOL 20 MG TABLET (NDC 72241003504) is labeled by Modavar Pharmaceuticals LLC, and CMS classifies it as a generic product.